Clinical Trials Browser

Phase 1/2 × RNA, Messenger × Dermatologic × Clear all

NCT00929019 2018-12-07

Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients

Phase 1/2 Terminated

Uveal Melanoma

NCT00204607 2007-04-19

Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients

Phase 1/2 Completed

Melanoma